Molecular Staging

Molecular Staging is addressing this demand with a portfolio of products and services based on technologies that are transforming the detection and measurement of both proteins and nucleic acids.

  • Incyte-Proprietary Clones on Microarrays

    Incyte has combined its in-house bioinformatics expertise and unparalleled genomic databases to develop several new prefabricated microarrays. Each contains up to 10,000 sequence-verified, Incyte-proprietary clones represented in our LifeSeq, ZooSeq, and PathoSeq databases and in our GeneAlbum reagent set. Read the rest of this entry »

    No Comments
  • pharmacogeneticsThis new Incyte program will focus on identifying the role of genetic diversity in disease and drug response by developing technologies and programs for the pharmaceutical industry in polymorphism discovery, genotyping and pharmacogenetics.

    The Future of Drug Development

    Understanding the key genetic differences between individuals will enable pharmaceutical researchers to create better therapeutics. Improved therapeutics can reach new levels by being able to differentiate between individuals according their predisposition to disease processes or susceptibility to adverse effects of medications. Read the rest of this entry »

    No Comments